483
ten23 health Valais AGten23 health Valais AG – FDA 483, Apr 24, 2019
Record Details
Swissfillon AG, a contract drug manufacturer in Visp, Switzerland, was cited for significant deficiencies in its aseptic processing areas. The inspection revealed inadequate environmental monitoring procedures, leading to microbial growth exceeding acceptance criteria, and a lack of proper cleaning and gowning instructions, resulting in observed improper aseptic techniques and potential product contamination.
View Company Profile
ID · 63581208-7264-4919-ade7-fd1f2306a687
Other documents for ten23 health Valais AG
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.